EXS2 📈 iShares TecDAX UCITS (DE) - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: DE0005933972 • Germany Equity

EXS2: German, Technology, Stocks, Equity, Funds

‣ Company URL: http://www.iShares.de ‣ Domicile: Germany ‣ Index Name: Morningstar Germany TME NR EUR

Additional Sources for EXS2 ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EXS2 ETF Overview

Market Cap in USD 812m
Category Germany Equity
IPO / Inception 2001-04-06

EXS2 ETF Ratings

Growth 5y 8.01%
Fundamental -
Dividend 9.09%
Rel. Strength Industry -88.6
Analysts -
Fair Price Momentum 27.41 EUR
Fair Price DCF -

EXS2 Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 30.3%

EXS2 Growth Ratios

Growth Correlation 3m 53.2%
Growth Correlation 12m 5.4%
Growth Correlation 5y 9.9%
CAGR 5y 1.94%
CAGR/Mean DD 5y 0.13
Sharpe Ratio 12m 0.11
Alpha -16.56
Beta 0.78
Volatility 15.42%
Current Volume 20.2k
Average Volume 20d 27.3k
What is the price of EXS2 stocks?
As of January 02, 2025, the stock is trading at EUR 30.21 with a total of 20,224 shares traded.
Over the past week, the price has changed by -1.10%, over one month by -1.21%, over three months by +0.72% and over the past year by +2.04%.
Is iShares TecDAX UCITS (DE) a good stock to buy?
Neither. Based on ValueRay Analyses, iShares TecDAX UCITS (DE) is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 8.01 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EXS2 as of January 2025 is 27.41. This means that EXS2 is currently overvalued and has a potential downside of -9.27%.
Is EXS2 a buy, sell or hold?
iShares TecDAX UCITS (DE) has no consensus analysts rating.
What are the forecast for EXS2 stock price target?
According to ValueRays Forecast Model, EXS2 iShares TecDAX UCITS (DE) will be worth about 30.3 in January 2026. The stock is currently trading at 30.21. This means that the stock has a potential upside of +0.17%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 30.3 0.2%